Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingjuan Wu
Observed names:
Qing-Juan Wu,
Qing-juan Wu
Institutions:
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital
Observed institutions:
China Academy of Chinese Medical Sciences,
Guang’anmen Hospital
ORCID:
0000-0003-1550-9419
Observed ORCID:
0000-0003-1550-9419
OpenAlex ID:
A5036018663
Efficacy, Chemical Constituents, and Pharmacological Actions of Radix Paeoniae Rubra and Radix Paeoniae Alba
2020
·
Yu-Qing Tan
, Heng-Wen Chen
, et al.
·
Frontiers in Pharmacology
·
171
PDF
Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems
2022
·
Li Wang
, Zheng-Min Cao
, et al.
·
Frontiers in Immunology
·
137
PDF
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025
·
Ziwei Guo
, Dongjie Wu
, et al.
·
Scientific Reports
·
124
NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
2022
·
Lixia Wang
, Wei Ren
, et al.
·
Frontiers in Molecular Neuroscience
·
123
PDF
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
2024
·
Yanbo Li
, Rui Qiang
, et al.
·
The Journal of Immunology
·
32
PDF
Extracellular Matrix Stiffness-Induced Mechanotransduction of Capillarized Liver Sinusoidal Endothelial Cells
2024
·
Qingjuan Wu
, Quanmei Sun
, et al.
·
Pharmaceuticals
·
18
Mendelian randomization of chronic hepatitis B and cardiovascular disease
2024
·
Dongjie Wu
, Feiyang Xiong
, et al.
·
Frontiers in Cardiovascular Medicine
·
10
PDF
Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective
2024
·
Qing-Juan Wu
, Wen-Liang Lv
·
IET Nanobiotechnology
·
10
PDF
Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial
2020
·
Qing-Juan Wu
, Wen-Liang Lv
, et al.
·
Trials
·
8
PDF
Ursolic and oleanolic acids suppress MNNG induced malignant transformation of human gastric mucosal epithelium by regulating the PI3 K/AKT pathway
2025
·
Mingkun Liu
, Jinsheng Dong
, et al.
·
Scientific Reports
·
6
PDF
Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications
2025
·
Dongjie Wu
, Jing Liu
, et al.
·
International Immunopharmacology
·
6
YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multi-center randomized controlled trial
2021
·
Qing-Juan Wu
, Wen-Liang Lv
, et al.
·
Trials
·
5
PDF
Traditional Chinese medicine on treating dilated cardiomyopathy: A protocol for systematic review and meta analysis
2020
·
Yuqing Tan
, Hengwen Chen
, et al.
·
Medicine
·
3
Neutrophil extracellular trapping network-associated biomarkers in liver fibrosis: machine learning and experimental validation
2025
·
Yanbo Li
, Yanping Lu
, et al.
·
Journal of Translational Medicine
·
2
PDF
Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial
2021
·
Pan-pan Tian
, Qing-juan Wu
, et al.
·
Trials
·
1
PDF
Efficacy and safety of traditional Chinese medicine injections in the treatment of acute myocardial infarction: A protocol for systematic review and network meta-analysis
2020
·
Wei Zhao
, Jun Li
, et al.
·
Medicine
·
1
Quantitative pharmacodynamics functional evaluation of Chinese medicine Qizhu formula in mice with dynamic near-infrared photoacoustic imaging
2024
·
Qing-Juan Wu
, Lan-Yu Chen
, et al.
·
Photoacoustics
YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multicentre randomised controlled trial.
2021
·
Qing-Juan Wu
, Wen-Liang Lv
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
18
Citation count:
657
H-index:
8
I10-index:
8
Year
Topic
Type